331 related articles for article (PubMed ID: 28321119)
21. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
Rees-Unwin KS; Faragher R; Unwin RD; Adams J; Brown PJ; Buckle AM; Pettitt A; Hutchinson CV; Johnson SM; Pulford K; Banham AH; Whetton AD; Lucas G; Mason DY; Burthem J
Br J Haematol; 2010 Feb; 148(4):534-43. PubMed ID: 19961478
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
23. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Zhang Q; Zhu Z; Guan J; Hu Y; Zhou W; Ye W; Lin B; Weng S; Chen Y; Zheng C
Mol Biotechnol; 2022 Dec; 64(12):1419-1430. PubMed ID: 35704163
[TBL] [Abstract][Full Text] [Related]
24. The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias.
Athanasakis E; Melloni E; Rigolin GM; Agnoletto C; Voltan R; Vozzi D; Piscianz E; Segat L; Dal Monego S; Cuneo A; Secchiero P; Zauli G
Oncotarget; 2014 Dec; 5(24):12635-45. PubMed ID: 25587027
[TBL] [Abstract][Full Text] [Related]
25. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
26. Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
[TBL] [Abstract][Full Text] [Related]
27. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
28. Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemia.
Zhou K; Zhang W; Zhang Q; Gui R; Zhao H; Chai X; Li Y; Wei X; Song Y
Oncotarget; 2017 Apr; 8(15):25469-25481. PubMed ID: 28424416
[TBL] [Abstract][Full Text] [Related]
29. LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations.
Kristensen L; Kristensen T; Abildgaard N; Royo C; Frederiksen M; Mourits-Andersen T; Campo E; Møller MB
Eur J Haematol; 2016 Aug; 97(2):175-82. PubMed ID: 26558352
[TBL] [Abstract][Full Text] [Related]
30. High-resolution melting analysis for rapid and sensitive NOTCH1 screening in chronic lymphocytic leukemia.
Xu JJ; Yao FR; Jiang M; Zhang YT; Guo F
Int J Mol Med; 2017 Feb; 39(2):415-422. PubMed ID: 28075457
[TBL] [Abstract][Full Text] [Related]
31. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.
Villamor N; Conde L; Martínez-Trillos A; Cazorla M; Navarro A; Beà S; López C; Colomer D; Pinyol M; Aymerich M; Rozman M; Abrisqueta P; Baumann T; Delgado J; Giné E; González-Díaz M; Hernández JM; Colado E; Payer AR; Rayon C; Navarro B; José Terol M; Bosch F; Quesada V; Puente XS; López-Otín C; Jares P; Pereira A; Campo E; López-Guillermo A
Leukemia; 2013 Apr; 27(5):1100-6. PubMed ID: 23295735
[TBL] [Abstract][Full Text] [Related]
32. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
[TBL] [Abstract][Full Text] [Related]
33. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.
Arruga F; Bracciamà V; Vitale N; Vaisitti T; Gizzi K; Yeomans A; Coscia M; D'Arena G; Gaidano G; Allan JN; Furman RR; Packham G; Forconi F; Deaglio S
Leukemia; 2020 Feb; 34(2):462-477. PubMed ID: 31467429
[TBL] [Abstract][Full Text] [Related]
34. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
35. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
[TBL] [Abstract][Full Text] [Related]
36. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
[TBL] [Abstract][Full Text] [Related]
38. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
[TBL] [Abstract][Full Text] [Related]
39. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
Onaindia A; Gómez S; Piris-Villaespesa M; Martínez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollán M; Martín-Acosta P; González-Rincón J; Menarguez J; Alvés J; Rodriguez-Pinilla SM; García JF; Mollejo M; Fraga M; García-Marco JA; Piris MA; Sánchez-Beato M
Haematologica; 2015 May; 100(5):e200-3. PubMed ID: 25552700
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]